Stock listing

F6T Stock Price, News, Filings & Events — Fate Therapeutics, Inc.

Selected listing: F6T · GETTEX · EUR · DE

F6T:GETTEX is the listing for Fate Therapeutics, Inc., a biotechnology company dedicated to developing cellular immunotherapies for cancer and immune disorders. Based in the United States, the company is focused on advancing innovative therapies through extensive research and development in regenerative medicine. With a market capitalization of approximately €280.9 million, Fate Therapeutics continues to make strides in the biotech sector, with ongoing news and filings related to its therapeutic advancements.

F6T:GETTEXEURDEUpdated July 24, 2026
Fate Therapeutics, Inc. logo
Ticker
F6T:GETTEX
Asset type
Stock
Market cap
$280.9M
Sector
Health Technology
Industry
Biotechnology
Exchange
GETTEX
Currency
EUR

Fate Therapeutics, Inc. F6T:GETTEX stock context

F6T:GETTEX is the listing for Fate Therapeutics, Inc., a biotechnology company dedicated to developing cellular immunotherapies for cancer and immune disorders. Based in the United States, the company is focused on advancing innovative therapies through extensive research and development in regenerative medicine. With a market capitalization of approximately €280.9 million, Fate Therapeutics continues to make strides in the biotech sector, with ongoing news and filings related to its therapeutic advancements.

Research Fate Therapeutics, Inc.

Alternate listings